Outcomes of Adding ADT and Pelvic Lymph Node Treatment to Prostate Bed Salvage Radiotherapy for Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial
Lancet 2022 May 14;399(10338)1886-1901, A Pollack, TG Karrison, AG Balogh, LG Gomella, DA Low, DW Bruner, JS Wefel, AG Martin, JM Michalski, SJ Angyalfi, H Lukka, SL Faria, GB Rodrigues, MC Beauchemin, RJ Lee, SA Seaward, AM Allen, DC Monitto, W Seiferheld, O Sartor, F Feng, HM SandlerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.